Clinical Trial Update: A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating arformoterol tartrate inhalation solution plus tiotropium bromide for reducing rehospitalization in chronic obstructive pulmonary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Brovana (arformoterol)
• Spiriva (tiotropium)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: TERMINATED | Results posted: 2017-10-02